Jul 22, 2020 / 01:00PM GMT
Operator
Dear ladies and gentlemen, welcome to the conference call of Medacta Group SA. At our customer's request, this conference will be recorded. (Operator Instructions)
May I now hand you over to Medacta CEO, Mr. Francesco Siccardi, who will lead you through this conference. Please go ahead, sir.
Francesco Siccardi - Medacta Group SA - Founder, CEO & Member of the Group Executive Management
Good afternoon, ladies and gentlemen, and thank you for joining Medacta's H1 unaudited top line figures. I will be presenting most of the slides today. And for the Q&A, I will be, together with Corrado Farsetta, able to answer any question you might have.
So if we go through the slides, we can, I think, jump after the disclosures, Corrado, on Slide #4. We have been, of course, affected during the H1 by the COVID situation. As we all know, this has caused elective surgeries to be deferred in many countries. The impact of these orthopedic surgeries deferral has been very different from country to country. And this clearly reflects on the differences across
Half Year 2020 Medacta Group SA Earnings Call Transcript
Mar 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers